Postmenopausal breast cancer and oestrogen associations with the IgA-coated and IgA-noncoated faecal microbiota

British Journal of Cancer

Volumn 118, Issue 4, 2018, Pages 471-479

  Goedert, James J ^a   Hua, Xing ^a   Bielecka, Agata ^b   Okayasu, Isao ^c   Milne, Ginger L ^d   Jones, Gieira S ^a   Fujiwara, Mutsunori ^e   Sinha, Rashmi ^a   Wan, Yunhu ^a   Xu, Xia ^f   Ravel, Jacques ^g   Shi, Jianxin ^a   Palm, Noah W ^a   Feigelson, Heather Spencer ^b,h  

^a NATIONAL CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^f FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYESTRADIOL; 2 HYDROXYESTRONE; 2 HYDROXYESTRONE 3 METHYL ETHER; 2 METHOXYESTRADIOL; 2 METHOXYESTRONE; 4 HYDROXYESTRONE; 4 METHOXYESTRADIOL; 4 METHOXYESTRONE; BACTERIAL RNA; ESTRADIOL; ESTROGEN; IMMUNOGLOBULIN A; PROSTAGLANDIN E; RNA 16S; UNCLASSIFIED DRUG; BACTERIAL DNA; RIBOSOME DNA;

ARTICLE; BACTERIAL METABOLISM; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CLOSTRIDIALES; CONTROLLED STUDY; EUBACTERIUM; FECES MICROFLORA; FEMALE; GENE SEQUENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTESTINE FLORA; MASS SPECTROMETRY; NONHUMAN; PARASUTTERELLA EXCREMENTIHOMINIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROSTAGLANDIN URINE LEVEL; RADIOIMMUNOASSAY; RUMINOCOCCUS; TAXONOMY; AGED; BACTERIUM; BREAST TUMOR; CLASSIFICATION; DNA SEQUENCE; DRUG EFFECT; FECES; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; URINE;

AGED; BACTERIA; BREAST NEOPLASMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA, BACTERIAL; DNA, RIBOSOMAL; ESTROGENS; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNOGLOBULIN A; MASS SPECTROMETRY; MIDDLE AGED; POSTMENOPAUSE; PROSTAGLANDINS E, SYNTHETIC; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 85042362092     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2017.435     Document Type: Article

References (45)

1. Adlercreutz H, Martin F (1980) Biliary excretion and intestinal metabolism of progesterone and estrogens in man. J Steroid Biochem 13(2): 231-244
2. Bardia A, Olson JE, Vachon CM, Lazovich D, Vierkant RA, Wang AH, Limburg PJ, Anderson KE, Cerhan JR (2011) Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Res Treat 126(1): 149-155
3. BoulangeCL, Neves AL, Chilloux J, Nicholson JK, Dumas ME (2016) Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med 8(1): 42
4. Bowers LW, Brenner AJ, Hursting SD, Tekmal RR, deGraffenried LA (2015) Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production. Breast Cancer Res Treat 149(1): 49-57
5. Bowers LW, Maximo IX, Brenner AJ, Beeram M, Hursting SD, Price RS, Tekmal RR, Jolly CA, deGraffenried LA (2014) NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandinaromatase interactions. Cancer Res 74(16): 4446-4457
6. Brown KA, Simpson ER (2012) Obesity and breast cancer: mechanisms and therapeutic implications. Front Biosci (Elite Ed) 4: 2515-2524
7. Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP (2016) DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods 13(7): 581-583
8. Cui Y, Shu XO, Gao YT, Cai Q, Ji BT, Li HL, Rothman N, Wu J, Yang G, Xiang YB, Zheng W (2014) Urinary prostaglandin E2 metabolite and breast cancer risk. Cancer Epidemiol Biomarkers Prev 23(12): 2866-2873
9. Dawson PA, Karpen SJ (2015) Intestinal transport and metabolism of bile acids. J Lipid Res 56(6): 1085-1099
10. Pedro M, Baeza S, Escudero MT, Dierssen-Sotos T, Gomez-Acebo I, Pollan M, Llorca J (2015) Effect of COX-2 inhibitors and other nonsteroidal inflammatory drugs on breast cancer risk: a meta-analysis. Breast Cancer Res Treat 149(2): 525-536
11. Feigelson HS, Bischoff K, Ardini MA, Ravel J, Gail MH, Flores R, Goedert JJ (2014) Feasibility of self-collection of fecal specimens by randomly sampled women for health-related studies of the gut microbiome. BMC Res Notes 7: 204
12. Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH, Gajer P, Ravel J, Goedert JJ (2012a) Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med 10: 253
13. Flores R, Shi J, Gail MH, Gajer P, Ravel J, Goedert JJ (2012b) Association of fecal microbial diversity and taxonomy with selected enzymatic functions. PLoS One 7(6): e39745
14. Fuhrman BJ, Feigelson HS, Flores R, Gail MH, Xu X, Ravel J, Goedert JJ (2014) Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women. J Clin Endocrinol Metab 99(12): 4632-4640
15. Gierach GL, Lacey JV, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, Brinton LA (2008) Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Breast Cancer Res 10(2): R38
16. Goedert JJ, Jones G, Hua X, Xu X, Yu G, Flores R, Falk RT, Gail MH, Shi J, Ravel J, Feigelson HS (2015) Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. J Natl Cancer Inst 107(8): djv147
17. Gunter MJ, Wang T, Cushman M, Xue X, Wassertheil-Smoller S, Strickler HD, Rohan TE, Manson JE, McTiernan A, Kaplan RC, Scherer PE, Chlebowski RT, Snetselaar L, Wang D, Ho GY (2015) Circulating adipokines and inflammatory markers and postmenopausal breast cancer risk. J Natl Cancer Inst; doi: 10.1093/jnci/djv169
18. Hong T, Liu A, Cai D, Zhang Y, Hua D, Hang X, Wu X (2013) Preoperative serum C-reactive protein levels and early breast cancer by BMI and menopausal status. Cancer Invest 31(4): 279-285
19. Kau AL, Planer JD, Liu J, Rao S, Yatsunenko T, Trehan I, Manary MJ, Liu TC, Stappenbeck TS, Maleta KM, Ashorn P, Dewey KG, Houpt ER, Hsieh CS, Gordon JI (2015) Functional characterization of IgA-targeted bacterial taxa from undernourished Malawian children that produce dietdependent enteropathy. Sci Transl Med 7(276): 276ra24
20. Key T, Appleby P, Barnes I, Reeves G. Group EHaBCC (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94(8): 606-616
21. Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Akhmedkhanov A, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR, Group EHBCC (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95(16): 1218-1226
22. Kim S, Campbell J, Yoo W, Taylor JA, Sandler DP (2017) Systemic levels of estrogens and PGE2 synthesis in relation to postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 26(3): 383-388
23. Kim S, Taylor JA, Milne GL, Sandler DP (2013) Association between urinary prostaglandin E2 metabolite and breast cancer risk: a prospective, case-cohort study of postmenopausal women. Cancer Prev Res (Phila) 6(6): 511-518
24. Kwa M, Plottel CS, Blaser MJ, Adams S (2016) The intestinal microbiome and estrogen receptor-positive female breast cancer. J Natl Cancer Inst; doi: 10.1093/jnci/djw029
25. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, Beiko RG, Huttenhower C (2013) Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 31(9): 814-821
26. Morris PG, Zhou XK, Milne GL, Goldstein D, Hawks LC, Dang CT, Modi S, Fornier MN, Hudis CA, Dannenberg AJ (2013) Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer. Cancer Prev Res (Phila) 6(5): 428-436
27. Okai S, Usui F, Ohta M, Mori H, Kurokawa K, Matsumoto S, Kato T, Miyauchi E, Ohno H, Shinkura R (2017) Intestinal IgA as a modulator of the gut microbiota. Gut Microbes 8(5): 486-492
28. Okayasu I, Ohnishi H, Sarandi I, Shojima J, Komatsu J, Oritsu M, Sasabe M, Nanami KO, Matsuura M, Azumi J, Ito S, Fujiwara M (2014) Significant increase of prostaglandin E-major urinary metabolite in male smokers: a screening study of age and gender differences using a simple radioimmunoassay. J Clin Lab Anal 28(1): 32-41
29. Palm NW, Zoete MR, Cullen TW, Barry NA, Stefanowski J, Hao L, Degnan PH, Hu J, Peter I, Zhang W, Ruggiero E, Cho JH, Goodman AL, Flavell RA (2014) Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158(5): 1000-1010
30. Peterson DA, McNulty NP, Guruge JL, Gordon JI (2007) IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe 2(5): 328-339
31. Plottel CS, Blaser MJ (2011) Microbiome and malignancy. Cell Host Microbe 10(4): 324-335
32. Ray A, Dittel BN (2015) Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis. Immunology 146(3): 359-368
33. Sampson JN, Falk RT, Schairer C, Moore SC, Fuhrman BJ, Dallal CM, Bauer DC, Dorgan JF, Shu XO, Zheng W, Brinton LA, Gail MH, Ziegler RG, Xu X, Hoover RN, Gierach GL (2017) Association of estrogen metabolism with breast cancer risk in different cohorts of postmenopausal women. Cancer Res 77(4): 918-925
34. Santiago-Rodriguez TM, Ly M, Daigneault MC, Brown IH, McDonald JA, Bonilla N, Vercoe EA, Pride DT (2015) Chemostat culture systems support diverse bacteriophage communities from human feces. Microbiome 3: 58
35. Silva MT, Galvao TF, Zimmerman IR, Pereira MG, Lopes LC (2012) Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence. Curr Pharm Des 18(26): 4047-4070
36. Subbaramaiah K, Morris PG, Zhou XK, Morrow M, Du B, Giri D, Kopelovich L, Hudis CA, Dannenberg AJ (2012) Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov 2(4): 356-365
37. Tamimi RM, Spiegelman D, Smith-Warner SA, Wang M, Pazaris M, Willett WC, Eliassen AH, Hunter DJ (2016) Population attributable risk of modifiable and nonmodifiable breast cancer risk factors in postmenopausal breast cancer. Am J Epidemiol 184(12): 884-893
38. Tikkanen MJ, Adlercreutz H, Pulkkinen MO (1973) Effects of antibiotics on oestrogen metabolism. Br Med J 2(5862): 369
39. Vogtmann E, Goedert JJ (2016) Epidemiologic studies of the human microbiome and cancer. Br J Cancer 114(3): 237-242
40. Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, Brown D, Stares MD, Scott P, Bergerat A, Louis P, McIntosh F, Johnstone AM, Lobley GE, Parkhill J, Flint HJ (2011) Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 5(2): 220-230
41. Warner DF (2014) Mycobacterium tuberculosis metabolism. Cold Spring Harb Perspect Med; doi:10.1101/cshperspect.a021121
42. Yiannakopoulou EC (2015) Aspirin and NSAIDs for breast cancer chemoprevention. Eur J Cancer Prev 24(5): 416-421
43. Ze X, Duncan SH, Louis P, Flint HJ (2012) Ruminococcus bromii is a keystone species for the degradation of resistant starch in the human colon. ISME J 6(8): 1535-1543
44. Zhao N, Chen J, Carroll IM, Ringel-Kulka T, Epstein MP, Zhou H, Zhou JJ, Ringel Y, Li H, Wu MC (2015) Testing in microbiome-profiling studies with MiRKAT, the microbiome regression-based kernel association test. Am J Hum Genet 96(5): 797-807
45. Zhong S, Chen L, Zhang X, Yu D, Tang J, Zhao J (2015) Aspirin use and risk of breast cancer: systematic review and meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev 24(11): 1645-1655